Prospective assessment of circulating tumor DNA in patients with metastatic uveal melanoma treated with tebentafusp

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
1 Online-Ressource.
Language
Englisch

Bibliographic citation
Prospective assessment of circulating tumor DNA in patients with metastatic uveal melanoma treated with tebentafusp ; volume:15 ; number:1 ; day:14 ; month:10 ; year:2024 ; pages:1-10 ; date:12.2024
Nature Communications ; 15, Heft 1 (14.10.2024), 1-10, 12.2024

Creator
Rodrigues, Manuel
Ramtohul, Toulsie
Rampanou, Aurore
Sandoval, José Luis
Houy, Alexandre
Servois, Vincent
Mailly-Giacchetti, Léah
Pierron, Gaelle
Vincent-Salomon, Anne
Cassoux, Nathalie
Mariani, Pascale
Dutriaux, Caroline
Pracht, Marc
Ryckewaert, Thomas
Kurtz, Jean-Emmanuel
Roman-Roman, Sergio
Piperno-Neumann, Sophie
Bidard, François-Clément
Stern, Marc-Henri
Renault, Shufang
Contributor
SpringerLink (Online service)

DOI
10.1038/s41467-024-53145-0
URN
urn:nbn:de:101:1-2501012102373.234199984179
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:34 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Rodrigues, Manuel
  • Ramtohul, Toulsie
  • Rampanou, Aurore
  • Sandoval, José Luis
  • Houy, Alexandre
  • Servois, Vincent
  • Mailly-Giacchetti, Léah
  • Pierron, Gaelle
  • Vincent-Salomon, Anne
  • Cassoux, Nathalie
  • Mariani, Pascale
  • Dutriaux, Caroline
  • Pracht, Marc
  • Ryckewaert, Thomas
  • Kurtz, Jean-Emmanuel
  • Roman-Roman, Sergio
  • Piperno-Neumann, Sophie
  • Bidard, François-Clément
  • Stern, Marc-Henri
  • Renault, Shufang
  • SpringerLink (Online service)

Other Objects (12)

Novel treatment paradigms for metastatic uveal melanoma

Novel treatment paradigms for metastatic uveal melanoma

Liquid biopsy proteomics of uveal melanoma reveals biomarkers associated with metastatic risk

Liquid biopsy proteomics of uveal melanoma reveals biomarkers associated with metastatic risk

The immune cell landscape of metastatic uveal melanoma correlates with overall survival

The immune cell landscape of metastatic uveal melanoma correlates with overall survival

Detection of neoplastic-immune hybrid cells with metastatic properties in uveal melanoma

Detection of neoplastic-immune hybrid cells with metastatic properties in uveal melanoma

Pembrolizumab as first-line treatment for metastatic uveal melanoma

Pembrolizumab as first-line treatment for metastatic uveal melanoma

Detection of metastases using circulating tumour DNA in uveal melanoma

Detection of metastases using circulating tumour DNA in uveal melanoma

Clinical determinants of long-term survival in metastatic uveal melanoma

Clinical determinants of long-term survival in metastatic uveal melanoma

Immune checkpoint inhibitors for metastatic uveal melanoma: a meta-analysis

Immune checkpoint inhibitors for metastatic uveal melanoma: a meta-analysis

The Current State of Systemic Therapy of Metastatic Uveal Melanoma

The Current State of Systemic Therapy of Metastatic Uveal Melanoma

Clinical determinants of long-term survival in metastatic uveal melanoma

Clinical determinants of long-term survival in metastatic uveal melanoma

Presumed Melanoma of Unknown Primary Origin Metastatic to the Choroid Mimics Primary Uveal Melanoma

Presumed Melanoma of Unknown Primary Origin Metastatic to the Choroid Mimics Primary Uveal Melanoma

Verification of EZH2 as a druggable target in metastatic uveal melanoma

Verification of EZH2 as a druggable target in metastatic uveal melanoma

Related objects